NCT 06247995 Brief Summary In the phase I part, to determine the…
Read more arrow_forwardNCT 05123482 Brief Summary This research study is studying a new compound,…
Read more arrow_forwardNCT 05332574 Brief Summary This is a Phase 1/2 study of GB263T…
Read more arrow_forwardNCT 05646862 Brief Summary This is a Phase III, multicenter, randomized, open-label,…
Read more arrow_forwardNCT 04802759 Brief Summary This is a Phase Ib/II, open-label, multicenter, randomized…
Read more arrow_forwardNCT 05981703 Brief Summary This is an open-label, multicenter, and nonrandomized dose…
Read more arrow_forwardNCT 05094336 Brief Summary The primary objective of Parts 1 and 2…
Read more arrow_forwardNCT 06130553 Brief Summary This is a first time in human (FTiH)…
Read more arrow_forwardNCT 05381909 Brief Summary This study aims to understand how safe and…
Read more arrow_forwardNCT 05935098 Brief Summary This study aims to test the safety, tolerability,…
Read more arrow_forward